Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AFM24
AFM24
ASCO: Affimed pivots to cancer combo after failing to meet monotherapy study continuation criteria
Fierce Biotech
Mon, 06/5/23 - 10:20 am
Affimed
ASCO 2023
AFM24